Dr. Kristin Marie McBeath, DO

Dr. McBeath practices at Ummc Maple Grove Cancer Infusion - Infusion Therapy - HOPD in Maple Grove, Minnesota.

Dr. McBeath's NPI, 1073855367, was assigned on March 25, 2013. Dr. McBeath graduated from Nova Southeastern University - College of Osteopathic Medicine in 2013. Dr. McBeath holds Minnesota license 65652.

Dr. McBeath's primary practice is Ummc Maple Grove Cancer Infusion - Infusion Therapy - HOPD, at 14500 99th Ave N, Maple Grove, MN 55369.

Dr. McBeath's primary practice is Ummc Maple Grove Cancer Infusion - Infusion Therapy - HOPD in Maple Grove, Minnesota. Dr. McBeath is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. McBeath to 1 more hospital, 9 medical groups, 4 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McBeath practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. McBeath's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. McBeath is board certified in gastroenterology by the American Board of Internal Medicine. Dr. McBeath is licensed in Minnesota.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, gastrointestinal bleeding, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. McBeath treats.

CMS data shows 369 Medicare services from Dr. McBeath across 10 procedure codes in 2024, for 154 Medicare patients. Medicare paid $26,799 for them.

CMS counts 154 Medicare patients who saw Dr. McBeath in 2024. The largest group is 65 to 74, with 74 patients. 62% of them have high blood pressure, and 58% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McBeath's median patient age at 50, with 53% women.

In 2024, Dr. McBeath wrote 481 Medicare Part D claims for 226 patients. 76% of them were for generic drugs. CMS names the drug for 380 of them, across 10 drugs with 11 or more claims each, at $46,893 in total drug cost. In 2023, CMS named 352 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. McBeath for performance year 2024, reported as part of a group. Dr. McBeath accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McBeath as offering telehealth. CMS counts 32 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. McBeath, more than 56% of the clinicians it reports for that procedure.

CMS Open Payments shows 13 general payments to Dr. McBeath from 5 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $773.

Dr. McBeath graduated from Nova Southeastern University - College of Osteopathic Medicine in 2013.

Dr. McBeath is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.